Enrique Grande, Director of the Medical Oncology Department at Quirónsalud, and Adjunct Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“NICE 2026 kidney cancer guideline (diagnosis andmanagement) – updated pathway from suspicion to staging/biopsy to risk-adapted treatment and follow-up.
Striking stat: 87% of UK stage 1a RCC is diagnosed incidentally, underscoring how hard early detection is in routine practice.”
Title: NICE 2026 guideline for the diagnosis and management of kidney cancer
Authors: Grant D. Stewart, Sarah Boyce, Marie C. Harrisingh, Olivia Crane
Read the Full Article.
Other articles featuring Enrique Grande on OncoDaily.
